Cadence Bank’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Cadence Bank's GILD Position: Q4 2025 in Review
Cadence Bank increased its Gilead Sciences (GILD) stake by 0.1% in Q4 2025, buying an estimated $2.19K and bringing the position to 17,752 shares worth $2.18M. The position accounts for 0.13% of the portfolio, ranked #112.
Cadence Bank first reported a position in GILD in Q4 2017 and has held it in 19 quarters since. The position peaked at $10.3M in Q3 2024. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- Cadence Bank held 17,752 shares of Gilead Sciences worth $2.18M as of Q4 2025.
- Cadence Bank bought 18 Gilead Sciences shares in Q4 2025, an estimated $2.19K.
- Gilead Sciences made up 0.13% of Cadence Bank's portfolio in Q4 2025, its #112 holding.
- Cadence Bank first reported a position in Gilead Sciences in Q4 2017 and has held it in 19 quarters since.
- Cadence Bank's Gilead Sciences position peaked at $10.3M in Q3 2024.
- 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on Cadence Bank's 13F filing for Q4 2025, filed 30 Jan 2026.